Oikonomidou O, Beresford MJ, Galve-Calvo E, Woeckel A, et al. Real-world clinical outcomes associated with first-line palbociclib and aromatase inhibitor therapy among patients with HR+/HER2- advanced breast cancer in Europe. Breast Cancer Res Treat 2025 Aug 6. doi: 10.1007/s10549-025-07707.
PMID: 40770162